DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
Indivior Solutions | Indivior PLC | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2020 | DOJ_CIVIL | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000 |
Novartis Hellas S.A.C.I. et al. | Novartis | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $233,000,000 |
Indivior, Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2020 | FTC | $10,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | employment discrimination | 2020 | OFCCP | $379,089 |
Bausch Health | Bausch Health | accounting fraud or deficiencies | 2020 | SEC | $45,000,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2020 | SEC | $112,800,000 |
Pacira Pharmaceuticals Inc. | Pacira BioSciences | False Claims Act and related | 2020 | USAO | $3,500,000 |
AbbVie Inc. | AbbVie | consumer protection violation | 2020 | CA-INS | $24,000,000 |
Purdue Pharma LP | Purdue Pharma | fraud | 2020 | DOJ_CIVIL | $8,344,000,000 |
Gilead Sciences, Inc. | Gilead Sciences | False Claims Act and related | 2020 | DOJ_CIVIL | $97,000,000 |
Biogen, Inc. | Biogen | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | environmental violation | 2020 | NJ-ENV | $10,800 |
Merck Sharp & Dohme Corp. | Merck | environmental violation | 2020 | VA-ENV | $20,925 |
Depuy Synthes Sales, Inc. | Johnson & Johnson | wage and hour violation | 2020 | CA-LCO | $57,488 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $19,900,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $51,250,000 |
Allergan PLC | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $62,500,000 |
Allergan PLC | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $120,000,000 |
Bausch & Lomb Inc. | Bausch Health | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $10,000,000 |
Celgene Corporation | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $34,000,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $48,000,000 |
Dr. Reddy's Laboratories Ltd. | Dr. Reddy's Laboratories | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $400,000 |
Forest Laboratories LLC | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $750,000,000 |
Lupin Pharmaceuticals Inc. | Lupin Limited | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $1,000,000 |
Momenta Pharmaceuticals Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $35,000,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $14,377,600 |
Ranbaxy Laboratories Ltd. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $3,500,000 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $85,000,000 |
Johnson & Johnson | Johnson & Johnson | consumer protection violation | 2020 | private lawsuit-federal | $6,315,000 |
Johnson & Johnson, Inc. | Johnson & Johnson | insurance violation | 2020 | NC-INS | $150,000 |
ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2020 | OSHA | $9,832 |
HIKMA PHARMACEUTICALS | Hikma Pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $20,479 |
AKORN OPERATING COMPANY, LLC | Akorn Inc. | workplace safety or health violation | 2020 | OSHA | $13,653 |
VERSUM MATERIALS, INC. | Merck KGaA (EMD) | environmental violation | 2020 | EPA | $17,600 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | environmental violation | 2021 | MA-AG | $600,000 |
Indivior plc | Indivior PLC | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $300,000,000 |
CSL Behring, LLC | CSL Limited | environmental violation | 2021 | EPA | $527,144 |
Incyte Corporation | Incyte Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $12,600,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2021 | USAO | $75,000,000 |
St. Jude Medical Inc. | Abbott Laboratories | drug or medical equipment safety violation | 2021 | DOJ_CIVIL | $27,000,000 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2021 | DOJ_CIVIL | $38,750,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $5,000,000,000 |
Endo Health Solutions | Endo International | off-label or unapproved promotion of medical products | 2021 | NY-AG | $50,000,000 |
Perrigo Company | Perrigo | employment discrimination | 2021 | NY-NYCCHR | $20,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $213,200,000 |
Sandoz Inc. | Sandoz Group | False Claims Act and related | 2021 | DOJ_CIVIL | $185,000,000 |
Apotex Corporation | Apotex Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $49,000,000 |
Allergan Finance LLC | AbbVie | off-label or unapproved promotion of medical products | 2021 | NY-AG | $200,000,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2021 | OFCCP | $560,000 |
Amyris, Inc. | Amyris | investor protection violation | 2021 | SEC | $300,000 |
Johnson & Johnson | Johnson & Johnson | product safety violation | 2021 | private lawsuit-federal | $2,500,000,000 |
Cherokee Pharmaceuticals | Merck | railroad safety violation | 2021 | FRA | $5,000 |
Pfizer Inc. | Pfizer | price-fixing or anti-competitive practices | 2021 | private lawsuit-federal | $345,000,000 |
ABBVIE US LLC | AbbVie | wage and hour violation | 2021 | IL-DOL | $25,973 |
Roche Diagnostics Corp. | Roche | False Claims Act and related | 2021 | private lawsuit-federal | $6,250,000 |
EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | workplace safety or health violation | 2021 | OSHA | $10,240 |
PBM NUTRITIONALS LLC | Perrigo | workplace safety or health violation | 2021 | OSHA | $14,502 |
ROCHE MOLECULAR SYSTEMS, INC. | Roche | workplace safety or health violation | 2021 | OSHA | $9,300 |
MYLAN TECHNOLOGIES, INC. | Viatris | workplace safety or health violation | 2021 | OSHA | $13,653 |
ASTRAZENECA PLP | AstraZeneca | environmental violation | 2021 | EPA | $18,960 |
CSL BEHRING LLC | CSL Limited | environmental violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Mallinckrodt ARD LLC | Mallinckrodt | False Claims Act and related | 2022 | DOJ_CIVIL | $260,000,000 |
Perrigo Co. | Perrigo | consumer protection violation | 2022 | CA-MULTI | $360,000 |
Pfizer | Pfizer | consumer protection violation | 2022 | CO-AG | $137,174 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Allergan Ltd. et al. | AbbVie | off-label or unapproved promotion of medical products | 2022 | FL-AG | $134,200,000 |
Endo Health Solutions and Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Pfizer Inc. | Pfizer | consumer protection violation | 2022 | KS-AG | $85,564 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Allergan Ltd. | AbbVie | off-label or unapproved promotion of medical products | 2022 | RI-AG | $7,500,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Pfizer | Pfizer | consumer protection violation | 2022 | VT-AG | $34,564 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | WV-AG | $78,000,000 |
Janssen Pharmaceuticals | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | WV-AG | $99,000,000 |
Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $10,000,000 |
Astellas Pharma US, Inc. | Astellas Pharma | campaign finance violation | 2022 | FEC | $7,500 |
Pfizer | Pfizer | consumer protection violation | 2022 | AZ-AG | $124,527 |
Akorn Operating Company LLC | Akorn Inc. | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
Pfizer, Inc. | Pfizer | consumer protection violation | 2022 | KS-AG | $85,000 |
Endo International plc | Endo International | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $450,000,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $2,370,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
Janssen Pharmaceuticals/Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Teva Parmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Novo Nordisk Inc | Novo Holdings A/S | False Claims Act and related | 2022 | USAO | $6,300,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | product safety violation | 2022 | private lawsuit-federal | $150,000,000 |
Biogen Inc. | Biogen | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | NH-AG | $40,500,000 |
Teva Pharmaceuticals, Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | NY-AG | $313,343,793 |
CSL Plasma Inc. | CSL Limited | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |